1-4 of 4
Rebecca Record
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASTX727 delivers superior response rates and associated survival benefit versus hydroxycarbamide/best supportive care in CMML and other MDS/MPN overlap syndromes: First results from the Phase 2 UK multicenter randomized ammo trial

Free
Daniel Wiseman, Jak Laight, Rebecca Boucher, Chhaya Sankhalpara, Rebecca Record, Jennifer Byrne, Onima Chowdhury, Dominic Culligan, Nicholas Cunningham, Srinivasan Narayanan, Rob Sellar, Kiran Batta, Manoj Raghavan, Dr. Emma Searle, Catherine Cargo, Steve Knapper, Austin Kulasekararaj
Journal: Blood
Blood (2025) 146 (Supplement 1): 488.
https://doi.org/10.1182/blood-2025-488
Published: 2025
Journal Articles

Patient experience sub-study of a randomised UK multicentre Phase 2 trial of ASTX727 versus hydroxycarbamide/best supportive care in myelodysplastic (MDS)/myeloproliferative (MPN) overlap syndromes (AMMO)

Free
Ashleigh Ward, Sally Taylor, Grant Punnett, Ramsay Devaraj, Chhaya Sankhalpara, Rebecca Record, Kiran Batta, Jennifer Byrne, Catherine Cargo, Onima Chowdhury, Dominic Culligan, Nicholas Cunningham, Steve Knapper, Austin Kulasekararaj, Srinivasan Narayanan, Manoj Raghavan, Rob Sellar, Daniel Wiseman, Janelle Yorke
Journal: Blood
Blood (2025) 146 (Supplement 1): 8164.
https://doi.org/10.1182/blood-2025-8164
Published: 2025
Journal Articles

Interim analysis of promise, a clinical study combining the BET inhibitor OPN-2853 with ruxolitinib in patients with advanced myelofibrosis experiencing an inadequate response to ruxolitinib

Free
Adam Mead, Bethan Psaila, Rebecca Boucher, Jiayi Wang, Rebecca Collings, Rebecca Record, Zsofia Nagy, Aishah Begum, Steve Knapper, Frances Wadelin, Manish Jain, Jenny O'Nions, Mary Frances McMullin, Sebastian Francis, Patrick Harrington, Srinivasan Narayanan, Kerry Inokuchi, Jackie Walling, Brain Huntley, Claire Harrison
Journal: Blood
Blood (2025) 146 (Supplement 1): 3794.
https://doi.org/10.1182/blood-2025-3794
Published: 2025
Journal Articles

Interim Analysis of Promise, a Clinical Study Combining the BET Inhibitor OPN-2853 with Ruxolitinib in Patients with Advanced Myelofibrosis Experiencing an Inadequate Response to Ruxolitinib

Free
Adam J Mead, Brian J P Huntly, Bethan Psaila, Claire Harrison, Rebecca Boucher, Jiayi Wang, Rebecca Collings, Zsofia Nagy, Rebecca Record
Journal: Blood
Blood (2024) 144 (Supplement 1): 3186.
https://doi.org/10.1182/blood-2024-205105
Published: 2024